We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PRU:NYSEPrudential Financial, Inc. Analysis

Data as of 2026-04-26 - not real-time

$94.21

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Prudential Financial (PRU) trades at $94.21, delivering a trailing P/E of 9.43, well below the industry average of 17.34, indicating a relative discount. The stock also offers a dividend yield of 5.78% with a payout ratio around 54%, suggesting room for continuation. Revenue growth of 31% and a forward EPS of $14.77 drive a forward P/E of 6.38, underscoring earnings momentum. Balance‑sheet strength is highlighted by $40.9 bn of cash versus $44.3 bn of debt, yielding a leverage ratio that remains manageable. Operating cash flow of $6.27 bn and free cash flow of $12.62 bn provide ample coverage for dividend payments. Technicals show the price below the 20‑day SMA (97.37) and 50‑day SMA (97.66), with a bearish MACD, yet the RSI of 39 hints at oversold conditions and a potential short‑term bounce toward the $92.66 support level.
Market sentiment is mixed; recent Barclays and Jefferies downgrades have pressured the stock, but the fear‑greed index at 88 (Extreme Greed) signals bullish bias among broader investors. Volume is trending higher, supporting liquidity for any upside move toward the $102.84 resistance. The DCF‑derived fair value implies roughly a 6% upside, aligning with analyst median target of $99. Beta of 0.94 and 30‑day volatility of 25.8% suggest price swings are pronounced but not excessively correlated to market swings. Geographic exposure to the U.S., Japan, and other markets adds moderate geographic risk, while regulatory risk remains typical for the insurance sector. Overall, the combination of attractive valuation, robust dividend, and solid cash generation makes PRU a compelling candidate for value‑oriented investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near support at $92.66
  • high dividend yield
  • oversold RSI suggests limited downside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • undervalued valuation with ~6% upside
  • strong cash flow and dividend sustainability
  • forward earnings growth and low forward P/E

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • stable, diversified insurance and investment businesses
  • consistent dividend and moderate payout ratio
  • robust balance sheet with ample liquidity

Key Metrics & Analysis

Financial Health

Revenue Growth31.20%
Profit Margin5.84%
P/E Ratio9.4
ROE11.36%
ROA0.42%
Debt/Equity124.48
P/B Ratio1.0
Op. Cash Flow$6.3B
Free Cash Flow$12.6B
Industry P/E17.3

Technical Analysis

TrendBearish
RSI39.8
Support$92.66
Resistance$102.84
MA 20$97.37
MA 50$97.66
MA 200$104.67
MACDBearish
VolumeIncreasing
Fear & Greed Index88.02

Valuation

Fair Value$1,327.42
Target Price$99.93
Upside/Downside6.08%
GradeUndervalued
TypeValue
Dividend Yield5.78%

Risk Assessment

Beta0.97
Volatility25.81%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.